China NT Pharma and Hilong raise a combined $342 million

Investors respond well to the Hong Kong IPOs of China NT Pharma and Hilong, helping them to raise a total of $342 million.

China NT Pharma and Hilong raise a combined $342 million

China NT Pharma Group raised HK$1.62 billion $208 million in a Hong Kong IPO last week, while Hilong Holdings pocketed HK$1.04 billion $134 million after a failed first attempt.

Both companies priced their shares at a discount to industrial peers. NT Pharma, a Shanghai-based supply chain and sales service provider for vaccines, sold 357 million shares at HK$4.54 each, the bottom end of an indicated price range that went up to...

To continue reading, please login or register for free

Print Edition

FinanceAsia Print Edition


  • 2nd Compliance Summit Southeast Asia

    17 August 2017  |  Singapore
    The 2017 Compliance Summit Southeast Asia will take an in-depth look at the key compliance considerations today with a focus on regulation and new ...